Use of recombinant interleukin-2 for intrapleural therapy of tumor-associated pleurisy.
Clinical efficiency of low dose Roncoleukin was studied in 30 patients with metastatic exudative pleurisy. Intrapleural therapy proved to be highly effective (overall effect reached 84%), was well tolerated, and improved patients' quality of life.
Titov
K S
KS
NN Blokhin Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia. ks-titov@mail.ru
Kiselevskii
M V
MV
Demidov
L V
LV
Mikhailova
I N
IN
Shubina
I Zh
IZh
Rodionova
L M
LM
Sinel'nikov
I E
IE
Topol'
K Yu
KY
Gritsai
A N
AN
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D016130:Immunophenotyping; D015552:Injections, Intralesional; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000473:pathology; D010998:Pleurisy / Q000188:drug therapy / Q000209:etiology; D016896:Treatment Outcome
D007376:Interleukin-2